PATENT CLAIM ANALYSIS

Application Number: 16093063
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "001700"]

Abstract:
Provided herein are compositions and methods for treating and preventing lung disease. In particular, provided herein are SP-A peptides and uses thereof in the treatment and prevention of lung disease (e.g., asthma or COPD).

Claim (Index 9):
The system of  claim 8 , wherein said device is a metered dose inhaler.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15855398', '13565644', '14473339', '11597320', '15639434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7595018792935371
- 35 USC 102 Novelty (BERT): 0.4973665028424776
- Combined Prediction Score: 0.7332883416484312
- Mean Citation Score: 224.800224
- Max Citation Score: 233.01675
- Similarity Product: 169.1552741755396

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test